The Robert Schattner Center, University of Pennsylvania, School of Dental Medicine 240 South 40th Street, Philadelphia, PA 19104-6030
Information on the impact of coronavirus (COVID-19) on patient care and School/University operations. Plus, resources for the Penn Dental Medicine community and alumni.
Dr. Elliot Hersh will explore the pharmacokinetics of Liposomal bupivacaine (Exparel®) and discuss its cost-effectiveness in the control of pain in dental outpatients. He will also present evidence-based data that supports or does not support some serious adverse drug interactions involving NSAID analgesic agents.